Category: News

In the lead up to this week’s The Insider: Meet the Fund Manager, Hedley Widdup from Lion Selection Group (ASX: LSX) sat down with Reach Markets to provide a bit of information about his investment strategy, industries of interest and view on the market.

Emojis: a quick and easy way to respond to a message without the need for words.

Another week, another round of assays for Felix Gold Ltd (ASX: FXG). The company has released gold and antimony findings from the final 17 holes from their flagship NW Array project in Alaska, where a maiden mineral resource estimate is due to be declared later this year.

VHM Limited (ASX: VHM) just keeps on making rare earth discoveries in the Loddon Mallee region of Victoria. Only 22km north of the company’s proposed Goschen treatment plant, drilling has confirmed the presence of valuable heavy minerals

Electric Vehicles are continuing on an upward trend as an industry, with many countries reporting higher sales or projecting increased adoption for 2023.

Felix Gold Limited (ASX: FXG) came to life in late 2020 to identify and acquire large-scale gold exploration prospects in the world-class Tintina Gold Province of Alaska. The company went on to make a major gold discovery in 2022 and is now just a few months away from delineating a maiden resource which Felix consider could pique the interest of potential acquirers.

It’s been another strong quarter for Far East Gold Ltd (ASX: FEG), with a raft of assays flooding in from their flagship Woyla Project in Indonesia that continued to show extensive high-grade gold and silver mineralisation throughout the system.

The markets have continued to run up, the next major resistance level is 7477. In a sign the Reserve Bank of Australia (RBA) is becoming less hawkish, the central bank decided to hold rates again this month – which the market has reacted well to

Spectur Limited (ASX: SP3), a company that develops AI-enabled tech aimed at improving security, surveillance, safety and productivity, recently released its Q4 FY23 activities report (quarter ending 30 June 2023) citing increased revenue from the year’s expansion initiatives and reiterated a profit-focussed strategy for FY24.

Clinical stage oncology company Prescient Therapeutics Ltd (ASX: PTX) has finished off another strong quarter with a healthy $21.8 million cash balance that will serve as a war chest for funding the next stage of their exciting clinical trials.

In the lead up to this week’s The Insider: Meet the Fund Manager, Emanuel Datt from Datt Capital sat down with Reach Markets to provide a bit of information about his investment strategy, industries of interest and view on the market.

Inflation signals continue to shape local market sentiment, as investors look towards next week’s Reserve Bank of Australia (RBA) interest rate decision. It’ll be one of the last for outgoing Governor, Philip Lowe, who is being replaced by Michele Bullock in September, with investors continuing to look for clues on how the change will impact future monetary policy.